Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-12.68%
↓ 206% below average
Average (9y)
11.94%
Historical baseline
Range
High:100.65%
Low:-32.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -12.68% |
| 2023 | -32.00% |
| 2022 | 12.39% |
| 2021 | -20.73% |
| 2020 | -27.55% |
| 2019 | 100.65% |
| 2018 | 3.63% |
| 2017 | 26.70% |
| 2016 | 58.60% |
| 2015 | 10.38% |